SS Innovations International (SSII) Cash & Equivalents Growth (3y) (2019 - 2026)
SS Innovations International (SSII) Cash & Equivalents Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -13.31% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 34.27% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 8.10% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 8.16% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 40.74% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | -2.57% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.72% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 38.28% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 32.23% |
| 10 | SS Innovations International | 730.50 Mn | 708.20 Mn | 7.10 Mn | 218.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 218.33% |
| Mar 31, 2026 | 229.04% |
| Dec 31, 2025 | 145.32% |
| Sep 30, 2025 | 122.74% |
| Jun 30, 2025 | 251.88% |
| Mar 31, 2025 | 257.68% |
| Dec 31, 2024 | 4.76% |
| Sep 30, 2024 | 2.40% |
| Jun 30, 2024 | 25.52% |
| Mar 31, 2024 | 44.11% |
| Dec 31, 2023 | 132.59% |
| Sep 30, 2023 | 2,027.49% |
| Jun 30, 2023 | 327.47% |
| Mar 31, 2023 | 253.90% |
| Dec 31, 2022 | 96.84% |
| Sep 30, 2022 | 157.92% |
| Jun 30, 2022 | 88.32% |
| Mar 31, 2022 | 77.98% |
| Dec 31, 2021 | 124.81% |
| Sep 30, 2021 | 27.00% |